Synthesis and Evaluation of Targeted Prodrugs for Cancer Treatment

von Jayant, Sreeja
Zustand: Neu
CHF 67.45
inklusive MwSt. - GRATIS LIEFERUNG
Jayant, Sreeja Synthesis and Evaluation of Targeted Prodrugs for Cancer Treatment
Jayant, Sreeja - Synthesis and Evaluation of Targeted Prodrugs for Cancer Treatment

Dir gefällt dieses Produkt? Sag's weiter!

CHF 67.45 inkl. USt.
Nur noch 1 Stück verfügbar Nur noch 1 Stück verfügbar Mehr als 10 Stück verfügbar
Lieferung: zwischen Donnerstag, 30. Juni 2022 und Montag, 4. Juli 2022
Verkauf & Versand: Dodax

Beschreibung

The Drug delivery system (DDS) consisted of several combination's of the anticancer drug doxorubicin (DOX), polymeric drug carrier polyethylene glycol (PEG), drug spacer citric acid (CA) and targeting moiety sialic acid (SA) which was evaluated in vitro for cytotoxicity on human ovarian carcinoma cells (A2780). The targeted prodrug conjugates with two copies of SA and DOX showed enhanced cytotoxicity when compared with non-targeted prodrugs and free DOX. Targeting of the conjugate to cancer cells by sialic acid and an increase in number of copies of targeting moiety and anticancer drug enhanced prodrug uptake by cancer cells and cytotoxicity of the prodrug. Analysis of synthesized conjugates by 1NMR, MALDI/TOF, and HPLC showed the formation of the PEG prodrugs. More than 40% of the drug was released from its conjugate in presence of esterase enzyme, whereas the conjugate was stable at pH 7.4. The data obtained suggest that PAMAM G4-SA dendrimer represents a promising vehicle for intracellular delivery of low solubility drugs such as paclitaxel. Developed dendrimer provides both cytoplasmic and nuclear delivery of therapeutics and enhances anticancer activity of paclitaxel.

Mitwirkende

Autor:
Jayant, Sreeja

Weitere Informationen

Biografie:
Completed her M.S. in Pharmaceutical Sciences from Rutgers, The State University of New Jersey, USA in 2007. Earlier, completed her Bachelor of Pharmacy from DSTSM College of Pharmacy, Solapur, Shivaji University.Her research involved molecular modeling, design, and synthesis of polymeric pro-drug conjugates for cancer targets.
Sprache:
Englisch
Seitenanzahl:
164
Medientyp:
Taschenbuch
Verlag:
LAP Lambert Academic Publishing

Stammdaten

Produkttyp:
Taschenbuch
Verpackungsabmessungen:
0.22 x 0.15 x 0.009 m; 0.29 kg
GTIN:
09783847339373
DUIN:
PFGPVA67CPO
CHF 67.45
Wir nutzen Cookies auf unserer Website, um deinen Besuch effizienter zu gestalten und dir mehr Benutzerfreundlichkeit bieten zu können. Klicke daher bitte auf "Cookies akzeptieren"! Nähere Informationen findest du in unserer Datenschutzerklärung.